ICICI Prudential Asset Management Co Ltd Increases Stock Position in The Clorox Company $CLX

ICICI Prudential Asset Management Co Ltd grew its position in The Clorox Company (NYSE:CLX) by 33.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 87,800 shares of the company’s stock after purchasing an additional 22,100 shares during the period. Clorox comprises about 1.0% of ICICI Prudential Asset Management Co Ltd’s portfolio, making the stock its 29th largest position. ICICI Prudential Asset Management Co Ltd’s holdings in Clorox were worth $8,853,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Wilkins Investment Counsel Inc. raised its position in Clorox by 250.6% in the fourth quarter. Wilkins Investment Counsel Inc. now owns 55,064 shares of the company’s stock worth $5,552,000 after acquiring an additional 39,360 shares during the period. JPMorgan Chase & Co. raised its position in Clorox by 27.0% in the third quarter. JPMorgan Chase & Co. now owns 928,654 shares of the company’s stock worth $114,506,000 after acquiring an additional 197,330 shares during the period. Morningstar Investment Management LLC raised its position in Clorox by 131.8% in the fourth quarter. Morningstar Investment Management LLC now owns 62,454 shares of the company’s stock worth $6,297,000 after acquiring an additional 35,506 shares during the period. Swiss Life Asset Management Ltd raised its position in Clorox by 221.4% in the third quarter. Swiss Life Asset Management Ltd now owns 86,426 shares of the company’s stock worth $10,656,000 after acquiring an additional 59,533 shares during the period. Finally, Birch Hill Investment Advisors LLC bought a new stake in Clorox in the fourth quarter worth about $22,103,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Price Performance

CLX opened at $98.48 on Friday. The company has a market capitalization of $11.91 billion, a price-to-earnings ratio of 15.99, a PEG ratio of 0.52 and a beta of 0.56. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. The firm has a 50-day moving average price of $96.58 and a 200-day moving average price of $105.26. The Clorox Company has a twelve month low of $84.70 and a twelve month high of $132.03.

Clorox (NYSE:CLX) last posted its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, topping the consensus estimate of $1.55 by $0.09. The firm had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company’s revenue was up .1% on a year-over-year basis. During the same quarter last year, the company earned $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Equities analysts expect that The Clorox Company will post 5.61 EPS for the current year.

Insider Buying and Selling at Clorox

In other Clorox news, Director Pierre R. Breber bought 5,000 shares of Clorox stock in a transaction dated Tuesday, May 5th. The stock was purchased at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the purchase, the director directly owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This trade represents a 38.46% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. 0.63% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several brokerages have commented on CLX. BNP Paribas Exane lowered their price objective on shares of Clorox from $128.00 to $97.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 12th. JPMorgan Chase & Co. lowered their price objective on shares of Clorox from $99.00 to $95.00 and set an “underweight” rating on the stock in a research report on Friday, May 1st. Zacks Research lowered shares of Clorox from a “hold” rating to a “strong sell” rating in a research report on Tuesday, May 12th. Jefferies Financial Group lowered their price objective on shares of Clorox from $139.00 to $125.00 and set a “buy” rating on the stock in a research report on Monday, May 4th. Finally, Weiss Ratings raised shares of Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, April 13th. One investment analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have given a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Reduce” and an average price target of $103.40.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.